Combined Impact of Mean and Variability of Non-HDL-Cholesterol on Cardiovascular Risk in Patients Undergoing Hemodialysis

被引：0
|
作者：
Lee, Hanbi [1 ]
Yang, Chul Woo [1 ]
Chung, Byung Ha [1 ]
机构：
[1] Seoul St Marys Hosp, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO366
引用
收藏
页码：705 / 706
页数：2
相关论文
共 50 条
  • [21] Remnant lipoprotein is superior to Non-HDL-cholesterol for prediction of cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals
    Nakamura, Takamitsu
    Hirano, Mitsumasa
    Kitta, Yoshmobu
    Kodama, Yasushi
    Obata, Jun-ei
    Takano, Hajime
    Kawabata, Ken-ichi
    Mende, Akira
    Kugiyama, Kiyotaka
    CIRCULATION, 2007, 116 (16) : 817 - 817
  • [22] APOLIPOPROTEIN B AND NON-HDL-CHOLESTEROL BETTER REFLECT RESIDUAL RISK THAN LDL-CHOLESTEROL IN STATIN-TREATED PATIENTS WITH ATHEROSCLEROSIS
    Johannesen, C. D. L.
    Langsted, A.
    Nordestgaard, B. G.
    Mortensen, M. B.
    ATHEROSCLEROSIS, 2021, 331 : E46 - E46
  • [23] ROSUVASTATIN REDUCES NON-HDL-CHOLESTEROL AND LIPOPROTEIN REMNANTS IN FREDRICKSON TYPE III HYPERLIPOPROTEINAEMIA PATIENTS
    Blom, D. J.
    Marais, A. D.
    Retterstol, K.
    Stein, E. A.
    Ycas, J.
    Gu, Z.
    Miller, E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 196 - 196
  • [24] Overestimation and Underestimation of Cardiovascular Risk by Apolipoprotein-B (Apo-B) Measurements, Compared to Currently Recommended Non-HDL-Cholesterol Goals in Patients with Diabetes and Hypertriglyceridemia
    Ganda, Om P.
    Jumes, Chris G.
    Abrahamson, Martin J.
    Molla, Michael
    DIABETES, 2011, 60 : A53 - A53
  • [25] HIGH HDL CHOLESTEROL INCREASES CARDIOVASCULAR RISK IN HYPERTENSIVE PATIENTS
    Manzi, Maria Virginia
    Trimarco, Valentina
    Izzo, Raffaele
    Morisco, Carmine
    Mone, Pasquale
    Falco, Angela
    Pacella, Daniela
    Gallo, Paola
    Lembo, Maria
    Santulli, Gaetano
    Trimarco, Bruno
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [26] HDL-cholesterol modulation and its impact on the management of cardiovascular risk
    Ferns, Gordon
    Keti, Vuyolethu
    ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 : 122 - 128
  • [27] Non-HDL Cholesterol and Long-Term cardiovascular risk
    Wolfram, Guenther
    AKTUELLE ERNAHRUNGSMEDIZIN, 2020, 45 (03): : 159 - 160
  • [28] HDL PROTEINS AS PREDICTORS OF CARDIOVASCULAR RISK AND MORTALITY IN DIABETIC PATIENTS ON HEMODIALYSIS
    Kopecky, Chantal M.
    Genser, Bernd
    Maerz, Winfried
    Wanner, Christoph
    Saemann, Marcus D.
    Weichhart, Thomas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 238 - 238
  • [29] Association of the triglyceride-glucose index with increased non-HDL-cholesterol as an indicator of cardiometabolic risk in population studies
    Coniglio, Raul Ignacio
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2022, 56 (04): : 415 - 426
  • [30] LECITHIN - CHOLESTEROL ACYLTRANSFERASE ACTIVITY, HDL-CHOLESTEROL AND APOLIPOPROTEIN A IN SERUM OF PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS
    JUNG, K
    NEUMANN, R
    PRECHT, K
    NUGEL, E
    SCHOLZ, D
    ENZYME, 1980, 25 (04) : 273 - 275
12345